Monday, 16 November 2026 X LinkedIn Bluesky RSS Send us news
LungDaily The Pulse of Respiratory Health
World COPD Day is on Wednesday 18 November · #WorldCOPDDay Our coverage →
New Paper Alert

High-dose flu vaccine linked to fewer hospitalisations than standard dose in older adults with lung disease

Pooled data from two randomised trials presented at ERS 2026 point to fewer flu and pneumonia hospitalisations with high-dose vaccine in adults aged 65 and over with lung disease.

“high-dose vaccine led to fewer flu and pneumonia hospitalizations than standard dose in adults 65+ with lung disease”— ATS AII

The American Thoracic Society's AII Assembly said in a post on X that pooled data from two randomised trials, presented at ERS 2026, showed that high-dose influenza vaccine led to fewer flu and pneumonia hospitalisations than standard-dose vaccine. The analysis covered adults aged 65 and over with lung disease.

The post framed the result as a question to clinicians, asking which flu vaccine their older patients with asthma or COPD are receiving. It carried the hashtag #AII and included a link to further material, which was not part of the text available.

The post did not name the two trials, give the number of participants, or state the size of the difference between the vaccines. It also did not say who carried out the pooled analysis, how lung disease was defined, or what period of follow-up was covered. The findings are therefore known only from this brief social media summary.

Original source

#copd#asthma#trial#therapeutics

Related stories

More in New Paper Alert

See all

LungDaily reports on public posts, papers and news from the lung health community. This article is based on the source linked above and was produced with AI-assisted tools under our editorial standards; facts and quotes are checked against the original before publication. Featured here, or spotted an error? Request a correction or removal.